Robust inference of kinase activity using functional networks
Open Access
- 19 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 12 (1), 1-12
- https://doi.org/10.1038/s41467-021-21211-6
Abstract
Mass spectrometry enables high-throughput screening of phosphoproteins across a broad range of biological contexts. When complemented by computational algorithms, phospho-proteomic data allows the inference of kinase activity, facilitating the identification of dysregulated kinases in various diseases including cancer, Alzheimer’s disease and Parkinson’s disease. To enhance the reliability of kinase activity inference, we present a network-based framework, RoKAI, that integrates various sources of functional information to capture coordinated changes in signaling. Through computational experiments, we show that phosphorylation of sites in the functional neighborhood of a kinase are significantly predictive of its activity. The incorporation of this knowledge in RoKAI consistently enhances the accuracy of kinase activity inference methods while making them more robust to missing annotations and quantifications. This enables the identification of understudied kinases and will likely lead to the development of novel kinase inhibitors for targeted therapy of many diseases. RoKAI is available as web-based tool at http://rokai.io.Keywords
This publication has 46 references indexed in Scilit:
- Mapping and analysis of phosphorylation sites: a quick guide for cell biologistsMolecular Biology of the Cell, 2013
- PTMcode: a database of known and predicted functional associations between post-translational modifications in proteinsNucleic Acids Research, 2012
- Oncogene-specific activation of tyrosine kinase networks during prostate cancer progressionProceedings of the National Academy of Sciences of the United States of America, 2012
- Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 studyThe Lancet Oncology, 2011
- Identifying Causal Genes and Dysregulated Pathways in Complex DiseasesPLoS Computational Biology, 2011
- Crizotinib inALK-Rearranged Inflammatory Myofibroblastic TumorThe New England Journal of Medicine, 2010
- Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5Nature, 2010
- eQED: an efficient method for interpreting eQTL associations using protein networksMolecular Systems Biology, 2008
- Systematic Discovery of In Vivo Phosphorylation NetworksCell, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005